Louisville Metabolic and Atherosclerosis Research Center, Louisville (United States of America)
Contributor content
Event: ESC CONGRESS 2019
Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)
Session: Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population